450 related articles for article (PubMed ID: 12821734)
1. Study and treatment of post Lyme disease (STOP-LD): a randomized double masked clinical trial.
Krupp LB; Hyman LG; Grimson R; Coyle PK; Melville P; Ahnn S; Dattwyler R; Chandler B
Neurology; 2003 Jun; 60(12):1923-30. PubMed ID: 12821734
[TBL] [Abstract][Full Text] [Related]
2. Cognitive function in post-treatment Lyme disease: do additional antibiotics help?
Kaplan RF; Trevino RP; Johnson GM; Levy L; Dornbush R; Hu LT; Evans J; Weinstein A; Schmid CH; Klempner MS
Neurology; 2003 Jun; 60(12):1916-22. PubMed ID: 12821733
[TBL] [Abstract][Full Text] [Related]
3. Ongoing discussion about the US clinical Lyme trials.
Fallon BA; Petkova E; Keilp JG; Britton CB
Am J Med; 2014 Feb; 127(2):e7. PubMed ID: 24462018
[No Abstract] [Full Text] [Related]
4. A randomized, placebo-controlled trial of repeated IV antibiotic therapy for Lyme encephalopathy.
Fallon BA; Keilp JG; Corbera KM; Petkova E; Britton CB; Dwyer E; Slavov I; Cheng J; Dobkin J; Nelson DR; Sackeim HA
Neurology; 2008 Mar; 70(13):992-1003. PubMed ID: 17928580
[TBL] [Abstract][Full Text] [Related]
5. Oral doxycycline versus intravenous ceftriaxone for European Lyme neuroborreliosis: a multicentre, non-inferiority, double-blind, randomised trial.
Ljøstad U; Skogvoll E; Eikeland R; Midgard R; Skarpaas T; Berg A; Mygland A
Lancet Neurol; 2008 Aug; 7(8):690-5. PubMed ID: 18567539
[TBL] [Abstract][Full Text] [Related]
6. Treating post Lyme disease: trying to solve one equation with too many unknowns.
Steiner I
Neurology; 2003 Jun; 60(12):1888-9. PubMed ID: 12821728
[No Abstract] [Full Text] [Related]
7. [Lyme borreliosis--the most frequent vector-borne infection in Denmark].
Lebech AM; Hansen K
Ugeskr Laeger; 2004 Jun; 166(25):2431-3. PubMed ID: 15283107
[No Abstract] [Full Text] [Related]
8. Antibiotic retreatment of Lyme disease in patients with persistent symptoms: a biostatistical review of randomized, placebo-controlled, clinical trials.
Delong AK; Blossom B; Maloney EL; Phillips SE
Contemp Clin Trials; 2012 Nov; 33(6):1132-42. PubMed ID: 22922244
[TBL] [Abstract][Full Text] [Related]
9. Two controlled trials of antibiotic treatment in patients with persistent symptoms and a history of Lyme disease.
Klempner MS; Hu LT; Evans J; Schmid CH; Johnson GM; Trevino RP; Norton D; Levy L; Wall D; McCall J; Kosinski M; Weinstein A
N Engl J Med; 2001 Jul; 345(2):85-92. PubMed ID: 11450676
[TBL] [Abstract][Full Text] [Related]
10. Safety and immunogenicity of a novel multivalent OspA vaccine against Lyme borreliosis in healthy adults: a double-blind, randomised, dose-escalation phase 1/2 trial.
Wressnigg N; Pöllabauer EM; Aichinger G; Portsmouth D; Löw-Baselli A; Fritsch S; Livey I; Crowe BA; Schwendinger M; Brühl P; Pilz A; Dvorak T; Singer J; Firth C; Luft B; Schmitt B; Zeitlinger M; Müller M; Kollaritsch H; Paulke-Korinek M; Esen M; Kremsner PG; Ehrlich HJ; Barrett PN
Lancet Infect Dis; 2013 Aug; 13(8):680-9. PubMed ID: 23665341
[TBL] [Abstract][Full Text] [Related]
11. Persistent Lyme Empiric Antibiotic Study Europe (PLEASE)--design of a randomized controlled trial of prolonged antibiotic treatment in patients with persistent symptoms attributed to Lyme borreliosis.
Berende A; ter Hofstede HJ; Donders AR; van Middendorp H; Kessels RP; Adang EM; Vos FJ; Evers AW; Kullberg BJ
BMC Infect Dis; 2014 Oct; 14():543. PubMed ID: 25318999
[TBL] [Abstract][Full Text] [Related]
12. Ceftriaxone therapy of chronic inflammatory arthritis. A double-blind placebo controlled trial.
Caperton EM; Heim-Duthoy KL; Matzke GR; Peterson PK; Johnson RC
Arch Intern Med; 1990 Aug; 150(8):1677-82. PubMed ID: 2383162
[TBL] [Abstract][Full Text] [Related]
13. Duration of antibiotic treatment in disseminated Lyme borreliosis: a double-blind, randomized, placebo-controlled, multicenter clinical study.
Oksi J; Nikoskelainen J; Hiekkanen H; Lauhio A; Peltomaa M; Pitkäranta A; Nyman D; Granlund H; Carlsson SA; Seppälä I; Valtonen V; Viljanen M
Eur J Clin Microbiol Infect Dis; 2007 Aug; 26(8):571-81. PubMed ID: 17587070
[TBL] [Abstract][Full Text] [Related]
14. Clinical aspects of neuroborreliosis and post-Lyme disease syndrome in adult patients.
Pfister HW; Rupprecht TA
Int J Med Microbiol; 2006 May; 296 Suppl 40():11-6. PubMed ID: 16524775
[TBL] [Abstract][Full Text] [Related]
15. Lyme disease.
Hayes E
Clin Evid; 2002 Dec; (8):721-33. PubMed ID: 12603910
[No Abstract] [Full Text] [Related]
16. Randomized Trial of Longer-Term Therapy for Symptoms Attributed to Lyme Disease.
Berende A; ter Hofstede HJ; Vos FJ; van Middendorp H; Vogelaar ML; Tromp M; van den Hoogen FH; Donders AR; Evers AW; Kullberg BJ
N Engl J Med; 2016 Mar; 374(13):1209-20. PubMed ID: 27028911
[TBL] [Abstract][Full Text] [Related]
17. Effect of prolonged antibiotic treatment on cognition in patients with Lyme borreliosis.
Berende A; Ter Hofstede HJM; Vos FJ; Vogelaar ML; van Middendorp H; Evers AWM; Kessels RPC; Kullberg BJ
Neurology; 2019 Mar; 92(13):e1447-e1455. PubMed ID: 30796143
[TBL] [Abstract][Full Text] [Related]
18. Safety and immunogenicity of a recombinant outer surface protein A Lyme vaccine.
Keller D; Koster FT; Marks DH; Hosbach P; Erdile LF; Mays JP
JAMA; 1994 Jun; 271(22):1764-8. PubMed ID: 8196120
[TBL] [Abstract][Full Text] [Related]
19. Neurocognitive abnormalities in children after classic manifestations of Lyme disease.
Bloom BJ; Wyckoff PM; Meissner HC; Steere AC
Pediatr Infect Dis J; 1998 Mar; 17(3):189-96. PubMed ID: 9535244
[TBL] [Abstract][Full Text] [Related]
20. Increased IFNα activity and differential antibody response in patients with a history of Lyme disease and persistent cognitive deficits.
Jacek E; Fallon BA; Chandra A; Crow MK; Wormser GP; Alaedini A
J Neuroimmunol; 2013 Feb; 255(1-2):85-91. PubMed ID: 23141748
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
